BlackRock Investment Institute

Macro insights

Delta variant - delay not a derailing

The spread of the highly transmissible Delta variant has caused renewed Covid-19 flare-ups around the world. In the UK, the variant already accounts for nearly 100% of infections and cases are still growing. Yet the advanced vaccine rollout appears to have weakened the link between cases and hospital admissions, allowing reopening to continue after a one-month delay.

Delta's different paces

Tracking the delta variant

Sources: BlackRock Investment Institute, with data from Notes: The chart shows the percentage of new sequenced cases attributed to the Delta variant, starting on the day where prevalence reached 5%.

In the U.S. and continental Europe, the Delta variant will likely reach peak transmission through the summer. Evidence so far suggests the spread in these regions may be less rapid than in the UK; we see vaccines similarly limiting hospitalizations. See the chart. We might see some delays in reopening, but we do not expect the restart to be derailed given the vaccine’s effectiveness.

Studies so far have shown that two doses of the vaccines have greater than 90% efficacy against hospitalization from the Delta variant. This supports our view of a broadening global economic restart.

Recent macro insights

Inflation and the restart
U.S. inflation increased slightly slower in July than in previous months, the latest consumer price index (CPI) data showed.
Challenges to EM restart
Emerging markets are significantly lagging behind developed markets in the vaccination rollout as vaccine supply remains a challenge for many of them.
Restart, not a recovery
U.S. GDP surpasses its pre-pandemic level, meaning the overall GDP shortfall will only be a fraction of that of the global financial crisis.
Elga Bartsch
Head of Macro Research
Read bio
Nicholas Fawcett
Macro Research

Stay ahead of markets with the latest insights from the BlackRock Investment Institute.

Please try again
First Name *
Please enter a valid first name
Last Name *
Please enter a valid last name
Email *
Please enter a valid email
Investor type *
This field is mandatory
Country *
This field is mandatory
Company *
This field is mandatory
Thank you
Thank you for your subscription!
We usually publish weekly insights on every Monday. Expect to receive your first newsletter from us this upcoming Monday.